Skip to content

Stryker SYK EV / EBITDA

EV / EBITDA at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
18.8×+4.2×
Boston Scientific logo
Boston ScientificBSX
28.3×-8.5×
Intuitive Surgical logo
Intuitive SurgicalISRG
77.8×+12.8×
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
10.8×-1.4×
Medtronic logo
MedtronicMDT
13.9×-1.5×
STERIS logo
STERISSTE
14.7×-3.5×

Other financials

Income statement

See full
Revenue$6.0B+2.6%
Gross profit$3.8B+1.8%
Operating income$936.0M+11.8%
Net income$745.0M+13.9%
EPS (diluted)$1.93+14.2%

Balance sheet

See full
Cash & equivalents$2.9B+24.1%
Total debt$14.4B-15.1%
Total assets$46.3B+0.6%

Cash flow

See full
Operating cash flow$581.0M+132%
CapEx$166.0M+35.0%
Free cash flow$415.0M+227%

Valuation

See full
Market cap$115.45B-11.4%
Enterprise value$126.95B-12.4%
P/E34.6×-11.0×
P/S4.6×-1.0×

Profitability

See full
Gross margin63.8%-0.1pp
Operating margin19.7%+4.4pp
Net margin13.2%+0.9pp

Returns & leverage

See full
Return on equity32.8%
Debt / equity0.8×
Current ratio2.1×+0.5×

Where this comes from

Calculated from Stryker’s reported figures.

Based on the most recent quarter.

The official record: Stryker’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stryker's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stryker's EV / EBITDA?
Stryker (SYK) reported EV / EBITDA of 22.1× in Q1 2026.
How has Stryker's EV / EBITDA changed year-over-year?
Stryker's EV / EBITDA decreased by 34.8% year-over-year, from 33.9× to 22.1×.
What is the long-term trend for Stryker's EV / EBITDA?
Over 4 years (2021 to 2025), Stryker's EV / EBITDA has grown at a -0.4% compound annual growth rate (CAGR), from 126.4× to 124.4×.
What does EV / EBITDA mean?
What the whole business (debt included) costs relative to its operating cash earnings.
How do you interpret EV / EBITDA?
Lets you compare companies with different leverage and tax positions on a like-for-like basis — the standard multiple in M&A. Lower can mean cheaper, subject to growth and capital intensity.
How does EV / EBITDA compare across companies?
Broadly comparable across non-financial sectors; not used for banks and insurers, where EBITDA is not meaningful.